Ocular Therapeutix, Inc.

NASDAQ: OCULHealthcare / Biotechnology / USA
4.37-0.1500-3.32%Vol 831 4901Y Perf -46.13%
Jun 14th, 2019 16:00
BID4.36 ASK4.37
Open4.50 Previous Close4.52
Pre-Market4.58 After-Trading4.37
 0.06 1.33%  - -%
Target Price
9.80 
Analyst Rating
Moderate Buy 1.60
Potencial %
124.26 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
     36.61
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)187 
Earnings Rating
Sell
Price Range Ratio 52wk %
34.30 
Earnings Date
6th Aug 2019

Today's Price Range

4.204.51

52wk Range

2.358.24

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
21.39%
3 Months
7.90%
6 Months
-18.01%
1 Year
-46.13%
3 Years
-24.66%
5 Years
-

Name / TickerPriceChg.Chg.%
OCUL4.37-0.1500-3.32
AAPL192.74-1.4100-0.73
GOOG1 085.35-3.4200-0.31
MSFT132.450.13000.10
XOM74.35-0.3300-0.44
WFC45.590.30000.66
JNJ140.09-0.6200-0.44
FB181.333.86002.18
GE10.23-0.0800-0.78
JPM109.820.28000.26
Earnings HistoryEstimateReportedSurprise %
Q01 2019-0.42-0.45-7.14
Q04 2018-0.37-0.42-13.51
Q03 2018-0.36-0.38-5.56
Q02 2018-0.37-0.370.00
Q01 2018-0.39-0.40-2.56
Q04 2017-0.58-0.4424.14
Q03 2017-0.54-0.540.00
Q02 2017-0.59-0.64-8.47
Earnings Per EndEstimateRevision %Trend
6/2019 QR-0.420.00-
9/2019 QR-0.37-2.78Negative
12/2019 FY-1.451.36Positive
12/2020 FY-0.778.33Positive
Next Report Date6th Aug 2019
Estimated EPS Next Report-0.42
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume831 490
Shares Outstanding (in ths.)42 837
Trades Count2 691
Dollar Volume3 336 217
Avg. Volume595 987
Avg. Weekly Volume1 172 908
Avg. Monthly Volume1 106 702
Avg. Quarterly Volume681 293
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (60.00 %)
4 (100.00 %)
5 (100.00 %)
Moderate Buy
1 (20.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (20.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
1.60
Strong Buy
1.00
Strong Buy
1.00

Ocular Therapeutix, Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Ocular Therapeutix aims to offer medication to replace the existing eye-drop therapy regimen, with the aim of lasting weeks or months with a one-time product application.

CEO: Antony C. Mattessich

Teplephone: +1 781 357-4000

Address: 15 Crosby Drive, Bedford 01730, MA, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

47%53%

Bearish Bullish

50%50%

Bearish Bullish

48%52%

News